Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Amyris has entered into a research agreement with a commercial license option with Janssen Biotech, Inc., part of Janssen Pharmaceutical Companies. Under the terms of the agreement, facilitated by Johnson & Johnson Innovation, the collaboration will ...
read more
Wednesday, August 03, 2016
The collaboration will explore the use of Amyris’s advanced microbe engineering technology to evaluate and develop multiple host microorganisms as alternatives to mammalian cell lines for the production of therapeutic recombinant proteins.
read more
Thursday, February 25, 2021
Amyris announced promising preliminary data in a pre-clinical study of its RNA COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges.
read more
Thursday, October 29, 2020
Amsbio announce a new rabbit and mouse recombinant monoclonal antibody development service.
read more
Thursday, February 06, 2014
AmSafe Bridport today announced the extended, ongoing contract with Kuehne + Nagel S.a.r.l to deliver precise logistical support for the DuPont™ Tyvek® Air Cargo Thermal Cover, which AmSafe Bridport distributes to its increasing number of European ...
read more
Amring Pharmaceuticals announced it is a recipient of the Supplier Horizon Award from Premier Inc.
read more
SSCI announced the availability of in vitro bioequivalence testing services.
read more
SSCI has implemented Mettler Toledo’s thermal analysis instruments that meet the updated regulatory data integrity standards, which are now being enforced by regulatory agencies in the United States and European Union as of Jan. 1, 2018.
read more
SSCI has enhanced its solid state characterization and method development capabilities, through the addition of the Cobalt Light Systems TRS100 Transmission Raman Spectrometer.
read more
Wednesday, September 05, 2018
The alliance will promote Metrion's electrophysiology and ion channel screening expertise to global pharmaceutical and biotechnology clients.
read more
AMRI has won renewal of a 10-year contract worth up to $39.5 million with the National Institutes of Health Blueprint Neurotherapeutics Network.
read more
Friday, February 23, 2018
AMRI announced expansion of its industry-leading container closure integrity testing (CCIT) services into the European Union.
read more
AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) for $110 million in cash. OsoBio is recognized as a premier ...
read more
AMRI has signed a definitive agreement to acquire all outstanding shares of Prime European Therapeuticals S.p.A., also known as "Euticals", in a transaction valued at approximately $358 million (EUR 315 million), consisting of shares of AMRI common ...
read more
Monday, February 11, 2013
AMRI announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI’s novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. This agreement ...
read more